BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 20087440)

  • 1. Smad4-mediated TGF-beta signaling in tumorigenesis.
    Yang G; Yang X
    Int J Biol Sci; 2010 Jan; 6(1):1-8. PubMed ID: 20087440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling.
    Ikeno S; Nakano N; Sano K; Minowa T; Sato W; Akatsu R; Sakata N; Hanagata N; Fujii M; Itoh F; Itoh S
    J Biol Chem; 2019 Mar; 294(13):4966-4980. PubMed ID: 30718277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TGF-β/SMAD4 signaling in cancer.
    Zhao M; Mishra L; Deng CX
    Int J Biol Sci; 2018; 14(2):111-123. PubMed ID: 29483830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PRAJA and ELF in TGF-beta signaling and gastric cancer.
    Mishra L; Katuri V; Evans S
    Cancer Biol Ther; 2005 Jul; 4(7):694-9. PubMed ID: 16096365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.
    Zhao S; Ammanamanchi S; Brattain M; Cao L; Thangasamy A; Wang J; Freeman JW
    J Biol Chem; 2008 Apr; 283(17):11293-301. PubMed ID: 18310076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Respiratory Factor-1, a Novel SMAD4 Binding Protein, Represses TGF-β/SMAD4 Signaling by Functioning as a Transcriptional Cofactor.
    Rajasekaran N; Song K; Lee JH; Wei Y; Erkin ÖC; Lee H; Shin YK
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMAD4 Feedback Activates the Canonical TGF-β Family Signaling Pathways.
    Liu L; Li Q; Yang L; Li Q; Du X
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMAD4 feedback regulates the canonical TGF-β signaling pathway to control granulosa cell apoptosis.
    Du X; Pan Z; Li Q; Liu H; Li Q
    Cell Death Dis; 2018 Feb; 9(2):151. PubMed ID: 29396446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
    J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
    Qiu W; Schönleben F; Li X; Su GH
    Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
    Geraldo MV; Yamashita AS; Kimura ET
    Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.
    Fullerton PT; Creighton CJ; Matzuk MM
    Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
    Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
    Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation.
    Osman A; Niles EG; LoVerde PT
    J Biol Chem; 2004 Feb; 279(8):6474-86. PubMed ID: 14630909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.